Axonics

AXNX · NASDAQ

$0.429−$0.0611 (−12.47%)TodayMarket closed ·
Prev close $0.4901

Key indicators

AXNX profitability and balance sheet ratios

EPS -$0.0004 in Q3 FY24, down 100.5% on a year earlier.

EPS by quarter
PeriodEPS
Q4 FY22$0.0139
Q1 FY23-$0.1904
Q2 FY23-$0.1495
Q3 FY23$0.0785
Q4 FY23$0.1331
Q1 FY24-$0.3753
Q2 FY24$0.1347
Q3 FY24-$0.0004

Where the money went

Q3 FY24, from revenue to net income

Axonics brought in $116.2M of revenue in Q3 FY24, +24.8% on a year earlier. It made a net loss of $0.0M.

Revenue
$116.2M
Costs, expenses and taxes
$116.2M
Net income
−$0.0M
Net margin
-0.0%

Income statement

Revenue and profit by reporting period

Revenue
Net income
AXNX income statement, quarterly
Line itemQ1 FY24Q2 FY24Q3 FY24
Revenue$91.4M$114.6M$116.2M
Gross profit$69.3M$89.1M$89.7M
Operating income−$15.4M$6.3M−$6.3M
Net income−$19.1M$6.9M−$0.0M
Diluted EPS-$0.38$0.13$0.00

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
AXNX balance sheet, quarterly
Line itemMar 2024Jun 2024Sep 2024
Total assets$715.6M$747.3M$774.2M
Total liabilities$88.5M$104.0M$109.7M
Shareholder equity$627.1M$643.3M$664.5M
Cash and short-term investments$332.8M$343.4M$345.2M
Total debt$0.0M$0.0M$0.0M

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
AXNX cash flow, quarterly
Line itemQ1 FY24Q2 FY24Q3 FY24
Operating cash flow−$9.2M$17.0M$0.9M
Investing cash flow$138.2M−$77.2M$70.1M
Financing cash flow$0.2M$0.2M$2.5M
Capital expenditure−$3.1M−$1.2M−$3.3M
Free cash flow−$12.3M$15.7M−$2.4M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.